Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Justices To Clarify What's Fair Game With 'Skinny Labels' No Photo Available

Ryan Davis

A new U.S. Supreme Court patent case that will require the justices to spell out what generic-drug makers can say when marketing drugs... (more story)

What JPM Tells Us About Healthcare Deals In 2026 No Photo Available

Yeji Jesse Lee

Coming out of one of the bellwether events for the healthcare industry, attorneys in the space are feeling pretty good about 2026.

Biopharma Industry Cheers US, EU's Joint AI Principles No Photo Available

Dan McKay

A cross-Atlantic effort by regulators shows that U.S. and European agencies can find common ground to guide the life sciences industry... (more story)